Micropulse yellow laser resolves leakage and retinal detachment without scarring or retinal damage.
By André Maia, MD, PHD
How should physicians apply this new information in their treatment of CRVO and BRVO?
By David M. Brown, MD, FACS
Reduced-fluence PDT is the current accepted treatment for CSR.
By Francesco Boscia, MD
Implant technology offers promising solutions to the burden of repeated injections for retinal diseases.
By Szilard Kiss, MD